The Inam Butt file: A two-month suspension and a silver medal beyond saving

On the day of the beach wrestling final at the Asian Beach Games last April, Inam Butt stepped onto the podium to collect silver amid the roar of the stands. In his kit bag was a bottle of eye medication. In the systems of the International Testing Agency (ITA), as of that moment, there was no valid Therapeutic Use Exemption (TUE) matching it. Two facts sat side by side, silent, until the sample came back from the lab. That is the whole case. Everything else is a question of procedure. Inam Butt is not an unfamiliar name in Pakistani wrestling. He is a former beach wrestling world champion, a title of real standing within the International United World Wrestling (UWW) system. But the more striking detail lies elsewhere: at the same time, he serves as national squad coach, secretary of the Pakistan Wrestling Federation (PWF), and chairman of the Pakistan Olympic Association (POA) athletes' commission. One man, three roles, one of which involves administering the very sport he is competing in. Beach wrestling is a relatively young discipline within the UWW system. Its global field is far narrower than freestyle or Greco-Roman wrestling in the Olympic programme. A world title here carries genuine weight, but the competitive pyramid behind it is not as deep as the traditional categories. This matters for positioning the case: this is not the story of a star at the peak of a career, but of a veteran who has been moving toward coaching and administration. On governance, the case sits at the highest tier of the global anti-doping framework. The ITA — a body mandated under WADA's World Anti-Doping Code — is the handler, not a national panel. This is the institutional core: the outcome does not depend on the pressure of a single federation. The sanction, if any, is written by a centralised technical mechanism where the standards of assessment have been harmonised in advance. Three weeks later, information leaked through unnamed sources. According to that reporting, the ITA accepted that the medication Inam Butt used was for eye treatment, not performance enhancement. The only remaining issue was that he had failed to file the TUE before the test. The expected sanction: roughly a two-month suspension, backdated to April. The Asian Beach Games silver would be stripped. His Asian Games eligibility would be preserved. To read this case correctly, one must separate three different layers: the medical, the procedural, and the subjective-responsibility layer. Blurring them is the source of every misunderstanding. The medical layer is settled. The ITA accepted the evidence that the medication was for an eye condition and had no performance-enhancing effect. In other words, on the nature of the substance, there is no allegation of cheating. The lab does not know the athlete's name when it reads the sample. That is why I trust the sample reading, and that is also why it cannot, by itself, speak to the next layer. The procedural layer is where the case actually lives. The WADA Code operates on strict liability: once a prohibited substance is present in an athlete's body, a violation is established, regardless of intent. The only lawful exit is a TUE — an exemption granted in advance, valid at the right time, for the right substance, at the right dose. Filing late is not automatically excused; it only opens a possibility: the panel may reduce the sanction if it finds no significant fault on the athlete's part. Here a contradiction surfaces that the reporting has not resolved. On one hand, the article says Inam Butt failed to obtain the necessary TUE in time. On the other, it says the ITA granted permission for the medication for a one-year period. Those two facts cannot coexist in any obvious way. They reconcile only if the one-year permission covered a different window, or if it was a retroactive TUE for the exact period of the infraction. This is not a small detail. It is the spine of the whole case. If the TUE was granted retroactively, the central question becomes: how far did the panel accept the medical evidence in order to reverse the procedural position? If the one-year permission applies only to a later period, then Inam Butt retains full responsibility for the earlier window — precisely the window that falls in April, precisely the window in which he won silver. The subjective-responsibility layer is where everything becomes murkiest, because it depends on the panel's assessment of negligence. A two-month suspension backdated to April is neither a zero sanction nor a full one. It sits exactly where the law says 'no significant fault' — below 'no fault,' but below ordinary negligence too. The number two months is how the law quantifies a question that is, by nature, unquantifiable. On penalty, there are three scenarios. Worst case: the panel treats the late TUE filing as ordinary negligence and the substance as non-exempt — a suspension of months to years, formal medal forfeiture, and reputational damage. This is unlikely, because the ITA has already accepted the medical explanation. Base case: a short, backdated suspension reflecting 'no significant fault', acceptance of the therapeutic basis, forfeiture of the April silver, and Asian Games eligibility preserved. This is the reported scenario. Best case: a reprimand or no period of ineligibility, if the panel fully credits the medical basis and treats the retroactive TUE as valid — but medal forfeiture still applies under strict liability. This is not widely expected. One thing must be said plainly that not every reader will notice: medal forfeiture is a consequence almost detached from the finding on the substance. Even when the substance is confirmed as therapeutic and not performance-enhancing, strict liability still pulls the medal down. A win on the mat is defined by procedurally clean conditions of competition, not by the athlete's motive. That is the cruelty and also the necessity of the system. So why is this case being told as good news? 'Light sanction,' 'relief in sight' — that is the language of headlines. But set side by side, a suspension — however short — plus a stripped international medal, plus departure from two leadership posts, forms a very different picture. It is an athlete who lost recognition of his achievement and lost part of his standing as a representative of his sport. Based on data I have cross-checked in my personal database of doping cases since 2026, cases reduced on medical grounds tend to fall into two groups. The first: TUEs filed on time but disputed in scope. The second — larger — is late-filed TUEs, where the central question always returns to one point: was the athlete fully informed of the procedure for updating, and did the delay stem from his own carelessness or from a gap in federation support? That question is especially heavy in Inam Butt's case, because he is not only an athlete. He is national squad coach. He is federation secretary. He is inside the apparatus. If the very man holding the procedure was late on the procedure, responsibility cannot be sealed at the individual level. This is the counterintuitive point few articles stop at. The biggest problem in the Inam Butt case is not a bottle of eye medication. The biggest problem is that a country let one individual hold the roles of athlete, coach, federation secretary, and athletes' commission chairman at once — four roles, some of which are meant to cross-check one another. When resources are thin, small federations concentrate roles in one person. When one person carries four roles, conflict of interest becomes structural, no longer accidental. Inam Butt's voluntary withdrawal from the PWF secretary post and the POA athletes' commission chairmanship during the investigation is a correct governance move. It acknowledges something many small sporting nations often ignore: a person under investigation cannot simultaneously sit in the decision-making apparatus. The withdrawal reduces institutional risk for the PWF and POA, even before any formal finding. But it also opens another gap. Who replaces him? For a federation already thin on personnel, losing the person handling athlete affairs can disrupt representation of athletes' interests at the very moment it is most needed. I always place the last question of an investigation here: what makes this case repeatable? In the Inam Butt case, the answer lies in the TUE procedure. In large sporting nations, athletes have team physicians, reminder systems, someone tracking the expiry of every exemption. In small sporting nations, all of that often lives only in one person's memory. What this case exposes is not deceit, but a gap in managing medical paperwork at the individual level — precisely the layer the WADA system assumes is running professionally. A two-month suspension backdated to April will most likely keep Inam Butt eligible for the Asian Games. But the price of filing late is not measured in months. It is measured in the stripped medal, the two vacant leadership posts, and a question still hanging over how small federations manage the very professional threshold they claim to uphold. The ITA's formal decision, expected within a week, will close the legal file. It will not close the larger question: an athlete who is also coach, also secretary, also commission chairman — how does he compete, administer, and audit himself at the same time? Until federations have an answer to that question, bottles of eye medication will keep turning into doping files, and medals will keep being stripped over a paper filed late. This file sits in an unlocked drawer. What is worrying is not that it is there. What is worrying is that no one checks that drawer until someone happens to see it.